At the end of June there was 2.9 quarters of funding on hand, that's enough to operate until towards the end of March next year, but under the ASX rules the company must tell the ASX how they will fund future operations when there's less than 2 quarters of funding on hand.
Therefore due to our new expected approval being in July there's going to have to be a CR prior to approval.
Theyre unlikely to receive good terms on a loan before FDA approval.
At the end of June there was 2.9 quarters of funding on hand,...
-
- There are more pages in this discussion • 5,680 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 38.0¢ | 36.5¢ | $1.324M | 3.541M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4056 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 653729 | 17 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |